FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20240925E00021
1. Date of relevant event: 24/09/2024
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02137
4. Name of listed corporation: Brii Biosciences Ltd. - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 731,161,556
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Hong
(Other names) Zhi
10. Name of director (Chinese):  
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1316There has been a change in nature of your interest in the shares because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
2101Beneficial owner
 
2101Beneficial owner
 
60,392         
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position54,638,7567.47
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position54,614,1487.47
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2301Trustee
Long position16,570,500
2307Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position16,000,000
2101Beneficial owner
Long position22,043,648
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4105Unlisted derivatives - Physically settled
31/10/202018/09/2030USD0USD0.680  5,000,000
Long position
4105Unlisted derivatives - Physically settled
31/10/202018/09/2030USD0USD0.680  3,000,000
Long position
4105Unlisted derivatives - Physically settled
18/09/202018/09/2030USD0USD0.680  4,000,000
Long position
4105Unlisted derivatives - Physically settled
17/09/202117/09/2031HKD1HKD47.600  2,593,333
Long position
4105Unlisted derivatives - Physically settled
17/09/202217/09/2031HKD1HKD47.600  262,500
Long position
4105Unlisted derivatives - Physically settled
20/01/2022 HKD0    486,000
Long position
4105Unlisted derivatives - Physically settled
17/09/2022 HKD0    45,500
Long position
4105Unlisted derivatives - Physically settled
21/09/202321/09/2032HKD1HKD6.454  2,562,000
Long position
4105Unlisted derivatives - Physically settled
21/09/2023 HKD0    170,000
Long position
4105Unlisted derivatives - Physically settled
23/08/202423/08/2033HKD1HKD3.010  3,369,500
Long position
4105Unlisted derivatives - Physically settled
23/08/2024 HKD0    272,625
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
   
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: In Box 24, upon vesting of the RSUs granted by the Company on September 21, 2022 under the Post-IPO Share Award Scheme of the Company, Zhi Hong received 60,392 shares by vesting 85,000 RSUs,. The other 24,608 shares had been deducted to settle the tax payments of the RSUs.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 25/09/2024
(dd/mm/yyyy)